Healthcare -
Biotechnology - NASDAQ - US
$ 0.5755
2.97 %
$ 168 M
Market Cap
-0.73
P/E
LYEL - TOTAL CURRENT LIABILITIES
Total Current Liabilities LYEL - Lyell Immunopharma, Inc.
34.5 M
LAST VALUE
-14.06%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR